Recent Publications and Sources of Information.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 91
- Publication type:
- Article
Works matching IS 10109609 AND DT 2001 AND VI 15 AND IP 2
Results: 43
1
2
Resurgence of sleeping sickness.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 89
- Publication type:
- Article
3
Avoid trastuzumab and anthracyclines.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 82
- Publication type:
- Article
4
Revised labelling for levocarnitine.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 82
- Publication type:
- Article
5
Neurotoxicity with aciclovir and valaciclovir.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 82
- Publication type:
- Article
6
Bupropion and seizures.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 82
- Publication type:
- Article
7
Propofol, heart failure and high dosages.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 81
- Publication type:
- Article
8
Sildenafil: not for use with nitrates.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 81
- Publication type:
- Article
9
Antipsychotics and high prolactin.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 81
- Publication type:
- Article
10
Herbal OTC remedy and hepatic dysfunction.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 80
- Publication type:
- Article
11
Clarithromycin: labelling change.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 80
- Publication type:
- Article
12
Rosiglitazone-associated hepatic and cardiovascular events.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 80
- Publication type:
- Article
13
Sleep attacks with pramipexole and ropinirole.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 80
- Publication type:
- Article
14
Ribavirin for combined use.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 79
- Publication type:
- Article
15
Peginterferon alfa-2b combined use: new labelling.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 79
- Publication type:
- Article
16
Oprelvekin: paediatric safety information.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 79
- Publication type:
- Article
17
Nesiritide for heart failure.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 79
- Publication type:
- Article
18
Oxycodone: strengthened warning.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 78
- Publication type:
- Article
19
Counterfeit filgrastim.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 78
- Publication type:
- Article
20
Phenylpropanolamine withdrawn from market.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 78
- Publication type:
- Article
21
Cerivastatin: marketing discontinued.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 77
- Publication type:
- Article
22
Paediatric amiodarone labelling changes.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 77
- Publication type:
- Article
23
Terbinafine and hepatic failure.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 77
- Publication type:
- Article
24
Itraconazole and congestive heart failure.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 76
- Publication type:
- Article
25
Bupropion update.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 76
- Publication type:
- Article
26
Bupropion safety information.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 76
- Publication type:
- Article
27
New Zealand and Australia: joint medicines regulatory body.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 76
- Publication type:
- Article
28
International Federation of Associations of Pharmaceutical Physicians.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 74
- Publication type:
- Article
29
Harmonization and international drug monitoring.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 72
- Publication type:
- Article
30
WHO guidelines on good clinical practice reviewed.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 71
- Publication type:
- Article
31
Use of placebo in clinical trials.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 70
- Publication type:
- Article
32
Pharmacopoeial quality of drugs supplied by Nigerian pharmacies.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 69
- Publication type:
- Article
33
Argentina takes action against black market pharmaceuticals.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 69
- Publication type:
- Article
34
Pharmaceutical legislation review.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 69
- Publication type:
- Article
35
Monitoring the emergence of antiretroviral resistance.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 68
- Publication type:
- Article
36
Implementation of the ICH common technical document.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 68
- Publication type:
- Article
37
Diagnosis of prion diseases soon possible?
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 67
- Publication type:
- Article
38
Evaluation of candidate HIV vaccines.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 65
- Publication type:
- Article
39
Group procurement of vaccines.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 62
- Publication type:
- Article
40
Treatment for tuberculosis and standard of care.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 61
- Publication type:
- Article
41
Cannabinoids in the management of pain.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 90
- Publication type:
- Article
42
Drug studies in developing countries.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 58
- By:
- Publication type:
- Article
43
Putting the 'partnership' into public-private partnerships.
- Published in:
- WHO Drug Information, 2001, v. 15, n. 2, p. 57
- By:
- Publication type:
- Article